№ lp_2_3_61259
File format: docx
Character count: 3903
File size: 167 KB
Year:
2017
Note:
Region / City
Theme:
Parenteral nutrition, neonatal care
Document type:
Proposal
Target audience:
Medical professionals, neonatal departments
Context description:
A proposal to switch from bespoke lipid syringes to standard lipid bags for neonatal parenteral nutrition.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / City:
Not specified
Topic:
Neuroscience, Lipid Transport, Myelin Growth
Document Type:
Research article
Organization / Institution:
Not specified
Author:
Wu, J., Kislinger, G., Duschek, J. et al.
Target Audience:
Researchers in Neuroscience, Cell Biology, Myelin Research
Period of Action:
Not specified
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Shanghai, Hangzhou, China
Topic:
Aging, Lung Metabolomics, Inflammaging
Document Type:
Research Study
Organization:
Shanghai Jiao Tong University, Zhejiang University
Author:
Lifeng Yan, Xiahui Ge, Huaqi Guo, Yu Xie, Weining Xiong, Lijun Zhu, Tianyu Zhou
Target Audience:
Researchers in respiratory and aging studies
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / City:
Shanghai, China; Neijiang, Sichuan, China; Adelaide, Australia
Topic:
Aquaculture, Lipid Metabolism, Myo-inositol
Document Type:
Research Article
Institution:
East China Normal University, Neijiang Normal University, Flinders University
Authors:
Xianyong Bu, Xiaodan Wang, Zhideng Lin, Chunling Wang, Lingyu Li, Shubin Liu, Qingchao Shi, Jian G. Qin, Liqiao Chen
Target Audience:
Researchers, Aquaculture Professionals, Environmental Health Specialists
Period of Study:
56 days
Date of Approval:
Not specified
Date of Modifications:
Not specified
Context:
This scientific article presents research on the effects of myo-inositol supplementation on the growth, antioxidant status, and lipid metabolism of Chinese mitten crabs in aquaculture.
Year:
2015
Region / City:
Zaria, Nigeria
Topic:
Biochemical effects of L- Ascorbic acid and α –Tocopherol on insulin resistance and lipid profile
Document Type:
Research Article
Institution:
Ahmadu Bello University, Usmanu Danfodiyo University
Author:
Y. Tanko, T.S Olaleye, K.A. Mohammed, A. Jimoh, M.A. Dewu, M.K. Dallatu, M. Yerima, A. Mohammed
Target Audience:
Researchers, Health Professionals
Period of Action:
2015
Date of Approval:
2015
Date of Modifications:
N/A
Keywords:
L- Ascorbic acid, α –Tocopherol, High fat diet, Liver enzymes, Lipid profile
Note:
Contextual Description
Year:
2026
Region / City:
Not specified
Subject:
Lipid nanoparticles, gene delivery, T cell transfection
Document type:
Research supplementary material
Institution:
Not specified
Author:
Not specified
Target audience:
Researchers in molecular biology and gene therapy
Experimental system:
Jurkat cells
Analyzed molecules:
DOPE, Cholesterol, C12-200, C14-PEG 2000, CAR-CD19BBz, ZsGreen pDNA
Methods:
Microfluidic mixing, electroporation, Lipofectamine comparison
Measured parameters:
Hydrodynamic diameter, polydispersity index, zeta potential, cell viability, transfection efficiency
Figures included:
S1–S5
Statistical analysis:
One-way ANOVA, unpaired t test
Year:
2026
Region / City:
Not specified
Subject:
Lipid mediators in epilepsy
Document type:
Supplementary tables and figures
Institution:
Not specified
Authors:
Not specified
Study population:
Patients with chronic epilepsy (n=8) and controls (n=6)
Methods:
LC-MS-MS analysis of plasma and cerebrospinal fluid
Analytes:
DHA, EPA, AA, resolvins, hydroxy-fatty acids, prostaglandins, lipoxins, leukotrienes
Variables analyzed:
Gender, seizure types, number of antiseizure medicines, age
Statistical analysis:
P values, multiple linear regression
Scale:
National Hospital Seizure Severity Scale (NHS3)
Correlation measures:
Plasma and CSF levels of RvD1 and RvE1 with clinical parameters
Year:
2019
Region / city:
Phitsanulok, Thailand; Penrith, Australia; Bloomington, IN, United States
Topic:
Pharmaceutical Sciences, Eye Health
Document type:
Original Article
Organization / institution:
Naresuan University, Western Sydney University, Indiana University, Innovare Academic Sciences Pvt Ltd
Author:
Pattravee Niamprem, Thomas J. Milla, Burkhardt S. Schuett, S. P. Srinivas, Waree Tiyaboonchai
Target audience:
Researchers, Academics in Pharmaceutical Sciences and Eye Health
Period of validity:
N/A
Approval date:
19 Nov 2018
Revision date:
19 Nov 2018
Year:
2023
Region / city:
Karaj, Iran
Subject:
Obesity, probiotics, metabolic health
Document type:
Clinical trial report
Organization / institution:
Tabriz University of Medical Sciences, Alborz University of Medical Sciences, Islamic Azad University
Author:
Faezeh Amani, Jamileh Ghalami, Leila Roozbeh-Nasiraie, Behzad Alaeddini, Vahidah Ebrahimzadeh Attari
Target audience:
Researchers, healthcare professionals, medical scientists
Period of validity:
2023
Approval date:
2023-06-08
Date of changes:
None
Keywords:
Probiotics, Lactobacillus, Omentin-1, Obesity, Lipid profile, Glycemic control
Year:
2023
Region / city:
Yemen
Subject:
Antihyperlipidemic effects, Moringa oleifera, Psidium guajava
Document type:
Research manuscript
Institution:
Lahjj University
Author:
Dhafer Shaher Mohammed Noman Aljaleedi
Target audience:
Scientific community, researchers in biochemistry and pharmacology
Date of approval:
Not specified
Date of revisions:
Not specified
Year:
2023
Institution:
Hokkaido University
Approval number:
17-0119
Animal model:
Male inbred WKAH/HkmSlc rats
Age of animals:
3 weeks
Sample size:
8 per group
Dietary intervention:
Control diet or 0.5 g CA/kg diet
Duration:
2 weeks
Housing conditions:
22 ± 2°C, 55 ± 5% humidity, 12 h light/dark cycle
Measurements:
Body weight, food intake, fecal lipid content
Analytical methods:
Cholesterol E-test, Triglyceride E-test, NEFA C-test
Reference diets:
AIN-93G-based control diet
Year:
2017
Region / city:
Eatontown, NJ
Subject:
Enterprise Infrastructure Solution (EIS) Management Software Request for Information (RFI)
Type of document:
Request for Information (RFI)
Organization / institution:
Department of Veterans Affairs, Technology Acquisition Center
Author:
Michael Frank
Target audience:
Contractors in telecommunications and related services
Period of validity:
August 30, 2017
Approval date:
August 30, 2017
Date of modifications:
None
Year:
2025
Region / city:
Centurion, Cape Town
Theme:
Email cleansing solution, maintenance, support, service delivery
Document type:
Request for Proposal (RFP)
Organization / institution:
SITA
Author:
SITA
Target audience:
Suppliers, bidders, technical service providers
Duration:
5 years
Approval date:
Not specified
Modification date:
Not specified
Year:
2019
Region / City:
United States
Topic:
Information Technology, Veterans Affairs, Healthcare
Document Type:
Performance Work Statement
Agency / Institution:
Department of Veterans Affairs, Office of Information & Technology
Author:
Not specified
Target Audience:
Contractors, VA staff, IT professionals
Period of Effectiveness:
June 27, 2019, onwards
Approval Date:
June 27, 2019
Amendments Date:
Not specified
Public Notice Number:
MOLIT Public Notice No. 2026-099
Issuing Authority:
Ministry of Land, Infrastructure and Transport
Country:
Republic of Korea
Program Name:
K-City Network Global Cooperation Program
Program Type:
Smart solution demonstration grant program
Legal Basis:
Act on the Promotion of Smart City Development and Industry, Article 30
Year:
2026
Announcement Date:
January 28, 2026
Application Period:
January 28, 2026 – March 17, 2026
Application Deadline:
March 17, 2026, 5:00 p.m. KST
Implementing Agency:
Korea Agency for Infrastructure Technology Advancement
Program Secretariat:
K-City Network Secretariat
Eligible Applicants:
Korean businesses and organizations
Consortium Requirement:
Mandatory consortium with overseas partner governments
Required Documents:
Project proposal, Letter of Intent or Memorandum of Understanding
Funding Amount:
300 million to 400 million KRW per project
Number of Selected Projects:
Up to six
Target Areas:
Transportation, energy, environment, security, urban administration
Geographical Scope:
Overseas cities and countries
Evaluation Method:
Proposal review and oral presentation
Contact Email:
[email protected]
Contact Telephone:
+82-31-389-6359, +82-31-389-6409
Year:
2024
Region / City:
Pretoria
Topic:
Procurement of Network Access Control (NAC) Solution
Document Type:
Bid Specification
Organization:
SITA
Author:
Not specified
Target Audience:
Suppliers / Bidders
Validity Period:
200 Days from the Closing Date
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Region / City:
European Union
Subject:
Pharmaceutical Product Information
Document Type:
Pharmaceutical Summary
Organization:
European Medicines Agency
Author:
European Medicines Agency
Target Audience:
Healthcare professionals
Period of validity:
Ongoing
Approval Date:
2026
Date of Modifications:
2026
Contextual Description:
The document outlines the product characteristics, indications, dosage, administration guidelines, and precautions for the pharmaceutical product Tysabri, as approved by the European Medicines Agency.
Year:
2025
Region / City:
Australia
Topic:
Pharmaceutical submission for drug listing
Document Type:
Pharmaceutical submission
Organization:
Janssen-Cilag Pty Ltd
Author:
Not specified
Target Audience:
Healthcare professionals, regulatory authorities
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
March 2025
Note:
Context
Year:
2026
Region / City:
EMEA
Subject:
Pharmaceutical Information
Document Type:
Product Information
Organization / Institution:
European Medicines Agency
Author:
European Medicines Agency
Target Audience:
Healthcare Professionals, Medical Practitioners
Validity Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / City:
Australia
Subject:
Chronic migraine, medicinal product submission
Document type:
Submission for PBS listing
Organization:
Novartis Pharmaceuticals Australia Pty. Limited
Author:
Not specified
Target audience:
Health professionals, pharmaceutical regulatory bodies
Period of validity:
Not specified
Date of approval:
2 July 2018
Date of amendments:
November 2023
Year:
2024
Region / City:
Australia
Topic:
Immunization, Respiratory Syncytial Virus (RSV), Vaccines
Document Type:
Submission
Organization:
SANOFI-AVENTIS AUSTRALIA PTY LTD
Author:
Not specified
Target Audience:
Healthcare professionals, policy makers, immunization program administrators
Period of validity:
From 2024
Approval Date:
24 November 2023
Date of Changes:
17 January 2025
Date of Submission:
7 March 2024
Note:
Contextual Description